Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Garrido

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Cancer Immunology, Immunotherapy : CII|January 2, 2017
Rejection versus escape: the tumor MHC dilemmaFederico Garrido, Francisco Ruiz-Cabello, Natalia Aptsiauri
Advances in Cancer Research|December 6, 2008
IFN inducibility of major histocompatibility antigens in tumorsBarbara Seliger, Francisco Ruiz-Cabello, Federico Garrido
Cancer Metastasis Reviews|April 16, 2021
MHC heterogeneity and response of metastases to immunotherapyIgnacio Algarra, Federico Garrido, Angel M Garcia-Lora
Seminars in Cancer Biology|April 3, 2002
HLA class I antigen abnormalities and immune escape by malignant cellsBarbara Seliger, Teresa Cabrera, Federico Garrido, et al.
Cancer Immunology, Immunotherapy : CII|July 14, 2010
The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible "hard" lesionsFederico Garrido, Ignacio Algarra, Angel M García-Lora
Oncoimmunology|August 2, 2014
A novel preclinical murine model of immune-mediated metastatic dormancyIrene Romero, Federico Garrido, Angel M Garcia-Lora
Cancer Research|November 21, 2014
Metastases in immune-mediated dormancy: a new opportunity for targeting cancerIrene Romero, Federico Garrido, Angel M Garcia-Lora
Cellular & Molecular Immunology|January 21, 2021
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapyPer Anderson, Natalia Aptsiauri, Francisco Ruiz-Cabello, et al.
Cancer Immunology, Immunotherapy : CII|December 17, 2004
Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cellsEva Jiménez, Angel Garcia-Lora, Marisol Martinez, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2012
Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011Natalia Aptsiauri, Teresa Cabrera, Angel Garcia-Lora, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Cancer Immunology, Immunotherapy : CII|January 2, 2017
Rejection versus escape: the tumor MHC dilemmaFederico Garrido, Francisco Ruiz-Cabello, Natalia Aptsiauri
Advances in Cancer Research|December 6, 2008
IFN inducibility of major histocompatibility antigens in tumorsBarbara Seliger, Francisco Ruiz-Cabello, Federico Garrido
Cancer Metastasis Reviews|April 16, 2021
MHC heterogeneity and response of metastases to immunotherapyIgnacio Algarra, Federico Garrido, Angel M Garcia-Lora
Seminars in Cancer Biology|April 3, 2002
HLA class I antigen abnormalities and immune escape by malignant cellsBarbara Seliger, Teresa Cabrera, Federico Garrido, et al.
Cancer Immunology, Immunotherapy : CII|July 14, 2010
The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible "hard" lesionsFederico Garrido, Ignacio Algarra, Angel M García-Lora
Oncoimmunology|August 2, 2014
A novel preclinical murine model of immune-mediated metastatic dormancyIrene Romero, Federico Garrido, Angel M Garcia-Lora
Cancer Research|November 21, 2014
Metastases in immune-mediated dormancy: a new opportunity for targeting cancerIrene Romero, Federico Garrido, Angel M Garcia-Lora
Cellular & Molecular Immunology|January 21, 2021
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapyPer Anderson, Natalia Aptsiauri, Francisco Ruiz-Cabello, et al.
Cancer Immunology, Immunotherapy : CII|December 17, 2004
Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cellsEva Jiménez, Angel Garcia-Lora, Marisol Martinez, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2012
Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011Natalia Aptsiauri, Teresa Cabrera, Angel Garcia-Lora, et al.
Pageof 10